Brickell Biotech CFO resigns to fully commit to Edgewise Therapeutics
BOULDER — R. Michael Carruthers, the chief financial officer and head accountant for Brickell Biotech inc. (Nasdaq: BII), is resigning […]
Source: BizWest
Check out market updates
BOULDER — R. Michael Carruthers, the chief financial officer and head accountant for Brickell Biotech inc. (Nasdaq: BII), is resigning […]
Source: BizWest